• Je něco špatně v tomto záznamu ?

Gamma knife radiosurgery for Cushing's disease and Nelson's syndrome

J. Marek, J. Ježková, V. Hána, M. Kršek, R. Liščák, V. Vladyka, L. Pecen,

. 2015 ; 18 (3) : 376-84.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16021083
E-zdroje Online Plný text

NLK ProQuest Central od 1999-06-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2011-03-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1999-06-01 do Před 1 rokem

PURPOSE: This paper presents our 18 years of experience in treating ACTH secreting adenomas (Cushing's disease and Nelson's syndrome) using the Leksell gamma knife (LGK) irradiation. METHODS: Twenty-six patients with Cushing's disease were followed-up after LGK irradiation for 48-216 months (median 78 months). Seventeen patients had undergone previous surgery, in nine patients LGK irradiation was the primary therapy. Furthermore, 14 patients with Nelson's syndrome were followed-up for 30-204 months (median 144 months). RESULTS: LGK treatment resulted in hormonal normalization in 80.7 % of patients with Cushing's disease. Time to normalization was 6-54 months (median 30 months). The volume of the adenoma decreased in 92.3% (in 30.7% disappeared completely). There was no recurrence of the disease. In all 14 patients with Nelson's syndrome ACTH levels decreased (in two patients fully normalized) their ACTH levels. When checked up 5-10 years after irradiation regrowth of the adenoma was only detected in one patient (9.1%), in 27.3% adenoma volume remained unchanged, in 45.4% adenoma volume decreased and in 18.2% adenoma completely disappeared. Hypopituitarism did not develop in any patient where the critical dose to the pituitary and distal infundibulum was respected. CONCLUSION: LGK radiation represents an effective and well-tolerated option for the treatment of patients with Cushing's disease after unsuccessful surgery and may be valuable even as a primary treatment in patients who are not suitable for, or refuse, surgery. In the case of Nelson's syndrome it is possible to impede tumorous growth and control the size of the adenoma in almost all patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16021083
003      
CZ-PrNML
005      
20160728111248.0
007      
ta
008      
160722s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11102-014-0584-7 $2 doi
024    7_
$a 10.1007/s11102-014-0584-7 $2 doi
035    __
$a (PubMed)25008022
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Marek, Josef $u Third Department of Medicine, First Medical Faculty, Charles University, U nemocnice 1, 128 02, Prague 2, Czech Republic.
245    10
$a Gamma knife radiosurgery for Cushing's disease and Nelson's syndrome / $c J. Marek, J. Ježková, V. Hána, M. Kršek, R. Liščák, V. Vladyka, L. Pecen,
520    9_
$a PURPOSE: This paper presents our 18 years of experience in treating ACTH secreting adenomas (Cushing's disease and Nelson's syndrome) using the Leksell gamma knife (LGK) irradiation. METHODS: Twenty-six patients with Cushing's disease were followed-up after LGK irradiation for 48-216 months (median 78 months). Seventeen patients had undergone previous surgery, in nine patients LGK irradiation was the primary therapy. Furthermore, 14 patients with Nelson's syndrome were followed-up for 30-204 months (median 144 months). RESULTS: LGK treatment resulted in hormonal normalization in 80.7 % of patients with Cushing's disease. Time to normalization was 6-54 months (median 30 months). The volume of the adenoma decreased in 92.3% (in 30.7% disappeared completely). There was no recurrence of the disease. In all 14 patients with Nelson's syndrome ACTH levels decreased (in two patients fully normalized) their ACTH levels. When checked up 5-10 years after irradiation regrowth of the adenoma was only detected in one patient (9.1%), in 27.3% adenoma volume remained unchanged, in 45.4% adenoma volume decreased and in 18.2% adenoma completely disappeared. Hypopituitarism did not develop in any patient where the critical dose to the pituitary and distal infundibulum was respected. CONCLUSION: LGK radiation represents an effective and well-tolerated option for the treatment of patients with Cushing's disease after unsuccessful surgery and may be valuable even as a primary treatment in patients who are not suitable for, or refuse, surgery. In the case of Nelson's syndrome it is possible to impede tumorous growth and control the size of the adenoma in almost all patients.
650    _2
$a adenom hypofýzy vylučující ACTH $x krev $x diagnóza $x patofyziologie $x chirurgie $7 D049913
650    _2
$a adenom $x krev $x diagnóza $x patofyziologie $x chirurgie $7 D000236
650    _2
$a mladiství $7 D000293
650    _2
$a adrenokortikotropní hormon $x krev $7 D000324
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a nádorové biomarkery $x krev $7 D014408
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a Nelsonův syndrom $x krev $x diagnóza $x patofyziologie $x chirurgie $7 D009347
650    _2
$a hypersekrece ACTH v hypofýze $x krev $x diagnóza $x patofyziologie $x chirurgie $7 D047748
650    _2
$a hypofýza $x metabolismus $x patofyziologie $x chirurgie $7 D010902
650    12
$a radiochirurgie $x škodlivé účinky $7 D016634
650    _2
$a indukce remise $7 D012074
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ježková, Jana
700    1_
$a Hána, Václav
700    1_
$a Kršek, Michal
700    1_
$a Liščák, Roman
700    1_
$a Vladyka, Vilibald
700    1_
$a Pecen, Ladislav
773    0_
$w MED00007807 $t Pituitary $x 1573-7403 $g Roč. 18, č. 3 (2015), s. 376-84
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25008022 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20160728111510 $b ABA008
999    __
$a ok $b bmc $g 1155753 $s 945611
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 18 $c 3 $d 376-84 $i 1573-7403 $m Pituitary $n Pituitary $x MED00007807
LZP    __
$a Pubmed-20160722

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...